AML	acute myeloid leukemia
ADPR	adenosine diphosphate ribosyl
ADCs	antibody–drug conjugates
AMPs	antimicrobial peptides
ANNs	artificial neural networks
BPDCNs	blastic plasmacytoid dendritic cell neoplasms
BR2	buforin II
CPE	Clostridium perfringens enterotoxin
CCR4	CC chemokine receptor 4
CATs	chimeric anticancer toxins
CML	chronic myelogenous leukemi a
CMML	chronic myelomonocytic leukemia
CL-4	claudin-4
BoNT	Clostridium botulinum neurotoxin
CAI	Codon Adaptation Index copper-containing redox protein
C-CPE	C-terminal fragment of Clostridium perfringens enterotoxin cupredoxin
ClyA	cytolysin A
CNF	cytotoxic necrotizing factor
CTL	cytotoxic T lymphocyte
PD1	programmed cell death protein-1
DT	diphtheria toxin
DTA	diphtheria toxin domain A
EF-2	elongation factor 2
EGFR	epidermal growth factor receptor
FR	folate receptor
GB3	globotriaosylceramide 3
HER2	human epidermal growth factor receptor 2
hIL-13	human IL-13
HTLV	human T-lymphotropic virus type
MTD	maximum tolerated dose
MSLN	mesothelin
MM	multiple myeloma
MDS	myelodysplastic syndrome
PBMCs	peripheral blood mononuclear cells
PBS	phosphate-buffered saline
PARP	poly ADP-ribose polymerase
STXA	Shiga toxin A
SEB	Staphylococcal enterotoxin type B
SP-A	Staphylococcus aureus protein A
TGF-a	transforming growth factor alpha
TAP	transporter-associated antigen processing
FDA	US Food and Drug Administration.